×
For best experience we recommend to activate Javascript in your browser.
CHRM4 antibody (AA 201-236)
This Rabbit Polyclonal antibody specifically detects CHRM4 in WB. It exhibits reactivity toward Human.
Quick Overview for CHRM4 antibody (AA 201-236) (ABIN6243266)
Target
See all CHRM4 Antibodies
CHRM4
(Cholinergic Receptor, Muscarinic 4 (CHRM4))
Reactivity
All reactivities for CHRM4 antibodies
Human
Host
All hosts for CHRM4 antibodies
Rabbit
Clonality
All clonalities for CHRM4 antibodies
Polyclonal
Conjugate
All conjugates for CHRM4 antibodies
This CHRM4 antibody is un-conjugated
Application
All applications for CHRM4 antibodies
Western Blotting (WB)
Clone
RB53327
Product Details anti-CHRM4 Antibody
(hide)
Binding Specificity
All epitopes for CHRM4 antibodies
AA 201-236
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This CHRM4 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 201-236 amino acids from human CHRM4.
Isotype
Ig Fraction
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:2000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Expiry Date
6 months
Target Details for CHRM4
(hide)
Target
CHRM4
(Cholinergic Receptor, Muscarinic 4 (CHRM4))
Alternative Name
CHRM4
Background
The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is inhibition of adenylate cyclase.
Molecular Weight
53049
UniProt
P08173
Pathways
cAMP Metabolic Process , Inositol Metabolic Process , Synaptic Membrane
Recently viewed
(hide)
Chat with us , powered by LiveChat